BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12114875)

  • 1. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
    Etchebehere EC; Macapinlac HA; Gonen M; Humm K; Yeung HW; Akhurst T; Scher HI; Larson SM
    Q J Nucl Med; 2002 Jun; 46(2):122-30. PubMed ID: 12114875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection.
    Ramos CD; Erdi YE; Gonen M; Riedel E; Yeung HW; Macapinlac HA; Chisin R; Larson SM
    Eur J Nucl Med; 2001 Feb; 28(2):155-64. PubMed ID: 11303885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction.
    Turlakow A; Larson SM; Coakley F; Akhurst T; Gonen M; Macapinlac HA; Kelly W; Leibel S; Humm J; Scardino P; Scher H; Hricak H
    Q J Nucl Med; 2001 Sep; 45(3):235-44. PubMed ID: 11788816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.
    Schöder H; Erdi YE; Chao K; Gonen M; Larson SM; Yeung HW
    J Nucl Med; 2004 Apr; 45(4):559-66. PubMed ID: 15073250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postinjection transmission scanning in myocardial 18F-FDG PET studies using both filtered backprojection and iterative reconstruction.
    van der Weerdt AP; Boellaard R; Knaapen P; Visser CA; Lammertsma AA; Visser FC
    J Nucl Med; 2004 Feb; 45(2):169-75. PubMed ID: 14960632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.
    Gutman F; Gardin I; Delahaye N; Rakotonirina H; Hitzel A; Manrique A; Le Guludec D; Véra P
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1510-9. PubMed ID: 14579091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
    Delbeke D; Martin WH; Patton JA; Sandler MP
    Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
    Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
    Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and clinical evaluation of iterative reconstruction (OSEM) in dynamic PET: quantitative characteristics and effects on kinetic modeling.
    Boellaard R; van Lingen A; Lammertsma AA
    J Nucl Med; 2001 May; 42(5):808-17. PubMed ID: 11337581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
    Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
    J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG.
    Nakamoto Y; Osman M; Wahl RL
    Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.
    Zielinski A; Behrendt FF; Verburg FA; Mottaghy FM; Krohn T
    Hell J Nucl Med; 2014; 17(3):194-9. PubMed ID: 25397625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction.
    Lonneux M; Borbath I; Bol A; Coppens A; Sibomana M; Bausart R; Defrise M; Pauwels S; Michel C
    Eur J Nucl Med; 1999 Jun; 26(6):591-8. PubMed ID: 10369944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
    Shreve PD; Grossman HB; Gross MD; Wahl RL
    Radiology; 1996 Jun; 199(3):751-6. PubMed ID: 8638000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
    Larson SM; Morris M; Gunther I; Beattie B; Humm JL; Akhurst TA; Finn RD; Erdi Y; Pentlow K; Dyke J; Squire O; Bornmann W; McCarthy T; Welch M; Scher H
    J Nucl Med; 2004 Mar; 45(3):366-73. PubMed ID: 15001675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment.
    Riddell C; Carson RE; Carrasquillo JA; Libutti SK; Danforth DN; Whatley M; Bacharach SL
    J Nucl Med; 2001 Sep; 42(9):1316-23. PubMed ID: 11535719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
    Cohade C; Osman M; Pannu HK; Wahl RL
    J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET.
    Stahl A; Ott K; Schwaiger M; Weber WA
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1471-8. PubMed ID: 15257418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.